FDA Mandates First-Ever Asbestos Testing Requirements for Cosmetics

Federal Rule Requires Manufacturers to Screen Every Talc Product Batch

The U.S. Food and Drug Administration announced comprehensive testing requirements for detecting asbestos in talc-containing cosmetics on December 26, 2024. The proposed regulation mandates specific scientific screening methods for all cosmetic products containing talc, implementing key 2022 Modernization of Cosmetics Regulation Act provisions. For the first time in FDA history, manufacturers must follow standardized testing protocols to identify asbestos contamination, a known carcinogen. The rule establishes both testing requirements and enforcement measures for non-compliant products.

5 Key Points

• FDA mandates two specific scientific methods for asbestos detection in all talc-containing cosmetics.
• Manufacturers must test each production batch or verify supplier testing certificates.
• The rule implements key requirements from the 2022 Modernization of Cosmetics Regulation Act.
• Products failing compliance will be deemed legally adulterated under federal law.
• Testing requirements follow peer-reviewed recommendations from the federal working group.

New Testing Protocols Target Known Carcinogen

The FDA’s proposed rule establishes two mandatory scientific testing methods for detecting asbestos contamination in cosmetic products containing talc. Manufacturers must employ both Polarized Light Microscopy (PLM) and Transmission Electron Microscopy with Energy Dispersive Spectroscopy and Selected Area Electron Diffraction (TEM/EDS/SAED) to screen products. The requirements emerged from recommendations by the Interagency Working Group on Asbestos in Consumer Products, formed in 2018 to evaluate testing methods. The FDA developed these protocols following extensive scientific review and peer-reviewed recommendations released in January 2022.

Manufacturing Standards and Compliance Requirements

The regulation requires cosmetic manufacturers to test representative samples from each production batch or lot of talc-containing products. Companies can alternatively test samples from each batch of raw talc ingredients before production begins. Under the new rules, manufacturers may rely on certificates of analysis from talc suppliers only after establishing and maintaining supplier reliability through verification testing programs. These requirements aim to prevent contaminated products from entering the consumer market.

Legal Framework and Enforcement Measures

The FDA structured enforcement provisions under the Federal Food, Drug, and Cosmetic Act to ensure manufacturer compliance. Products containing asbestos will be classified as legally adulterated under Section 601(a) of the Act. Companies failing to meet testing or recordkeeping requirements face product classification as adulterated under Section 601(c). The regulation implements expanded FDA authority granted by the Modernization of Cosmetics Regulation Act of 2022.

Get a free legal case review today

Did you develop any of the following injuries after being exposed to Fire Fighting Foam (AFFF)? * Choose one Ulcerative Colitis Kidney Cancer Pancreatic Cancer Testicular Cancer Prostate Cancer Bladder Cancer Thyroid Disease Liver Cancer Non-Hodgkin's Lymphoma None of the above Were you exposed to Fire Fighting Foam (AFFF)? *

YesNo

Which medication(s) did you take during your pregnancy? * Choose one Tylenol Acetaminophen Alka-Seltzer Coricidin Dayquil Excedrin FluTherapy Midol Mucinex Nyquil Panadol Robitussin Sinex Sudafed Theraflu Other Medication(s) Was your child diagnosed with Autism, ADHD or another condition? * Choose one Autism/Autism Spectrum Disorder (ASD) Attention Deficit Hyperactivity Disorder (ADHD) Asperger’s Syndrome Kanner’s Syndrome Childhood Disintegrative Disorder Pervasive Developmental Disorder Other Medical Condition How old was your child at the time of diagnosis? *

Under 18 years old18+ years old

Did the accident occur within the last 2 years? *

YesNo

First Name *

Last Name *

Email Address *

ZIP Code *

Phone Number *

What is your case type? * Choose one -------------------- Asbestos Baby Formula Camp Lejeune Clergy Abuse CPAP Elmiron Exactech Firefighting Foam FTX Exchange Hair Relaxer Hernia Mesh Paraquat PFAS Roundup Sex Abuse Social Media Talcum Powder Tepezza Tylenol -------------------- Birth Injury Car Accident FELA Medical Malpractice Motorcycle Accident Slip and Fall Trucking Accident Uber & Lyft Rideshare Workplace Injury Weight Loss Wrongful Death -------------------- Something Else

Human Verification *

I understand and agree that (a) submitting this form does not create an attorney-client relationship, (b) I am not already represented by an attorney for this matter, (c) the information I submit will be shared with a law firm, and (d) I have read and accepted the terms and conditions of the Privacy Policy, Terms of Service and Legal Disclaimer. Further, I consent to being contacted by a law firm or its agent after submitting this request.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Scientific Development and Implementation Process

The testing requirements resulted from years of research and evaluation. Following the creation of the Interagency Working Group in the fall of 2018, the FDA held a public meeting in February 2020 to present initial findings. The agency released peer-reviewed scientific recommendations in January 2022, forming the foundation for current testing protocols. This systematic approach ensures testing methods meet rigorous scientific standards while remaining practical for industry implementation.

Consumer Protection and Industry Benefits

The FDA designed the regulation to reduce consumer exposure to asbestos through contaminated cosmetic products. The agency aims to prevent asbestos-containing products from reaching store shelves by implementing standardized testing requirements. The proposal provides additional benefits to manufacturers by reducing costly product recalls related to asbestos contamination while establishing clear compliance guidelines for the cosmetics industry.